Atlas Trials

Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.

Clinical trial NCT01876459 · UNKNOWN

Trial details

NCT number
NCT01876459
Sponsor
University Hospital, Strasbourg, France
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
"Alzheimer's Disease" and "Lewy Body Disease"
Start date
2013-04-01
Primary completion
2015-04-01
Enrollment
265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.